Keisuke Omori Selected Research

Keisuke Omori Research Topics

Disease

10	Neoplasms (Cancer) 01/2023 - 01/2017
4	Squamous Cell Carcinoma of Head and Neck 11/2023 - 01/2017
3	Osteonecrosis (Kienbock's Disease) 12/2022 - 01/2022
3	Edema (Dropsy) 01/2019 - 01/2014
2	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2018
2	Infections 09/2022 - 01/2019
2	Pain (Aches) 09/2022 - 01/2021
2	Acute Lung Injury 01/2019 - 01/2016
2	Inflammation (Inflammations) 01/2015 - 01/2014
1	Dental Caries (Decay, Dental) 01/2024
1	Extranodal Extension 11/2023
1	Hypoxia (Hypoxemia) 10/2023
1	Pathologic Neovascularization 10/2023
1	Retinal Hemorrhage 10/2023
1	Eye Diseases (Eye Disease) 10/2023
1	Suppuration 09/2022
1	Alveolar Bone Loss 09/2022
1	Margins of Excision 01/2022
1	Osteoporosis 01/2022
1	Carcinogenesis 01/2021
1	Colitis-Associated Neoplasms 01/2021
1	Colitis 01/2021
1	Cysts 01/2021
1	Hemorrhage 01/2021
1	Prognathism 01/2021
1	Surgical Wound Infection 01/2021
1	Temporomandibular Joint Disorders (Temporomandibular Joint Disorder) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Disease Progression 12/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2017
1	Carcinoma (Carcinomatosis) 09/2017
1	Anaplasia 09/2017
1	Pneumonia (Pneumonitis) 01/2016
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016
1	Dermatitis 01/2014

Drug/Important Bio-Agent (IBA)

7	Prostaglandin D2IBA 10/2023 - 01/2014
5	ProstaglandinsIBA 10/2023 - 01/2016
3	Bone Density Conservation AgentsIBA 12/2022 - 01/2022
3	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 01/2018 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 01/2014
2	LipidsIBA 01/2021 - 01/2016
2	Arachidonic Acid (Vitamin F)IBA 01/2021 - 01/2018
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
2	Cetuximab (Erbitux)FDA Link 01/2020 - 01/2017
2	CytokinesIBA 12/2018 - 01/2018
2	Croton OilIBA 01/2014 - 01/2014
1	PRG Barrier CoatIBA 01/2024
1	Epithelial Cell Adhesion MoleculeIBA 11/2023
1	Cisplatin (Platino)FDA LinkGeneric 11/2023
1	Growth Factor ReceptorsIBA 10/2023
1	Retinaldehyde (Retinal)IBA 10/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Cathepsin KIBA 01/2022
1	11,15- dioxo- 9- hydroxy- 2,3,4,5- tetranorprostan- 1,20- dioic acidIBA 01/2021
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	NADP (NADPH)IBA 01/2021
1	Ointments (Pastes)IBA 01/2021
1	Povidone-Iodine (Betadine)FDA LinkGeneric 01/2021
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	IsoprostanesIBA 01/2021
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2021
1	AlpelisibIBA 01/2020
1	AcidsIBA 01/2019
1	ChemokinesIBA 12/2018
1	A-factor (Streptomyces)IBA 01/2018
1	prostaglandin D2 receptorIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Interleukin-1 (Interleukin 1)IBA 01/2018
1	LipocalinsIBA 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2017
1	LipopolysaccharidesIBA 01/2016
1	Thromboxane A2 (A2, Thromboxane)IBA 01/2016
1	Hydrochloric Acid (Hydrogen Chloride)FDA Link 01/2016
1	indium-bleomycinIBA 01/2016
1	Thromboxane Receptors (Thromboxane Receptor)IBA 01/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016
1	Oleic Acid (Oleate)IBA 01/2016
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2015

Therapy/Procedure

2	Therapeutics 12/2022 - 09/2022
2	Tooth Extraction (Tooth Extractions) 09/2022 - 01/2022
1	Chemoradiotherapy 11/2023
1	Neck Dissection (Radical Neck Dissection) 11/2023
1	Topical Administration 01/2021
1	Osteotomy 01/2021
1	Radiotherapy 09/2017
1	Glossectomy 09/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2014